Cerus Corporation (CERS) is a medical devices company listed on US.
Latest reported CERS revenue for 2025-12-31 was $233.8M. Net income was -$15.6M. CERS currently screens at market cap $294.4M.
Use this CERS page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the CERS quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the CERS SEC filings page. Lician reads the product cache first so this HTML stays unique to Cerus Corporation even when a live quote feed is slow.
Latest cached year on this hub. Full CERS income, balance, and cash tables.